Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
Clinical trial NCT01818713 · UNKNOWN
Trial details
- NCT number
- NCT01818713
- Sponsor
- The Netherlands Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.